Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8702) , 1360-1363
- https://doi.org/10.1016/0140-6736(90)91242-3
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levelsJournal of Internal Medicine, 1990
- Genetics of the quantitative Lp(a) lipoprotein traitHuman Genetics, 1989
- Lp(a) lipoprotein as a risk factor for myocardial infarctionJAMA, 1986
- Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
- Family similarities in the age at coronary death in familial hypercholesterolaemia.BMJ, 1977
- Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart diseaseClinical Genetics, 1974
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974
- FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASEThe Lancet, 1973
- A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEMActa Pathologica Microbiologica Scandinavica, 1963